Analysed MICROBOT MEDICAL INC (MBOT:NASDAQ) News Sources
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
26-05-2026
yahoo.com
Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System
02-06-2026
yahoo.com
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
09-06-2026
yahoo.com
Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations
16-06-2026
yahoo.com
Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System
23-06-2026
yahoo.com
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
25-06-2026
yahoo.com
Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader
30-06-2026
yahoo.com
Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026
07-07-2026
yahoo.com
What is the current price of MICROBOT MEDICAL INC (MBOT:NASDAQ)?
The current price of MICROBOT MEDICAL INC (MBOT:NASDAQ) is $1.69.
MICROBOT MEDICAL INC (MBOT:NASDAQ) absolute price change since previous trading day?
The absolute price change of MICROBOT MEDICAL INC (MBOT:NASDAQ) since the previous trading day is $-0.05.
MICROBOT MEDICAL INC (MBOT:NASDAQ) percentage price change since previous trading day?
The percentage price change of MICROBOT MEDICAL INC (MBOT:NASDAQ) since the previous trading day is -2.8736%.
What is the most recent average sentiment score for MICROBOT MEDICAL INC (MBOT:NASDAQ)?
The most recent average sentiment score for MICROBOT MEDICAL INC (MBOT:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for MICROBOT MEDICAL INC (MBOT:NASDAQ)?
The most recent sentiment for MICROBOT MEDICAL INC (MBOT:NASDAQ) is .
SEC-8K** Filing Available For MICROBOT MEDICAL INC (MBOT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.